GCT 101
Alternative Names: GCT-101Latest Information Update: 04 Dec 2023
At a glance
- Originator Kidswell Bio; Orthorebirth
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Alveolar bone loss
Most Recent Events
- 04 Dec 2023 GCT 101 is still in early research for Alveolar-bone-loss in Japan (Kidswell Bio pipeline, December 2023)
- 28 Jun 2023 No recent reports of development identified for research development in Alveolar-bone-loss in Japan
- 01 Jul 2021 Gene Techno Science is now called Kidswell Bio